Brusatol attenuated proliferation and invasion induced by KRAS in differentiated thyroid cancer through inhibiting Nrf2.

Z GongL XueA C VlantisC A van HasseltJ Y K ChanJ FangR WangY YangD LiX ZengM C F TongGeorge Gong Chen

Published in: Journal of endocrinological investigation (2023)

Collectively, this study suggests that Nrf2 could be a promising therapeutic target in KRAS-mediated dedifferentiation of thyroid cancer.

Keyphrases